Mesenchymal Stromal Cells (MSC)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mesenchymal Stromal Cells (MSC), covering 2025-10-31 to 2025-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)